$Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer$

Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer

Background: Advanced urothelial cancer (aUC) is often characterized by rapid symptomatic disease progression, making early disease control of particular importance. Circulating tumor DNA (ctDNA) is a promising prognostic biomarker and emerging evidence shows that a single time point/measurement of c...

Full description

Saved in:

Bibliographic Details
Main Authors:	B. Miron, G. Li, J.C.F. Quintanilha, A. Clark, T. Scott, J.S. Ross, G.R. Oxnard, L.W. Pasquina, R.P. Graf, S. Gupta
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	ESMO Real World Data and Digital Oncology
Subjects:	circulating tumor DNA tumor fraction urothelial cancer real-world progression real-world overall survival liquid biopsy comprehensive genomic profiling
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949820123000048
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world data
by: M.J. Emmett, et al.
Published: (2024-06-01)

Real-World Clinical Outcomes with First-Line Systemic Treatment and Avelumab Maintenance in US Patients with Locally Advanced or Metastatic Urothelial Carcinoma: The SPEAR Bladder-II Study
by: Sneha Sura, et al.
Published: (2025-03-01)

Maintenance Therapy With Avelumab for Patients With Metastatic Urothelial Carcinoma: A Real‐World, Ambispective RAVE‐Bladder Study
by: Ilya Tsimafeyeu, et al.
Published: (2025-02-01)

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045
by: Anke Richters, et al.
Published: (2025-01-01)

READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma
by: L. Antonuzzo, et al.
Published: (2024-09-01)

Perampanel in adjunctive therapy of patients with brain tumor-related epilepsy: real-world data
by: G. G. Samsonova, et al.
Published: (2023-01-01)

The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
by: Huaixi Ge, et al.
Published: (2025-02-01)

Real-world data studies in oncology: analysis of the Russian publications
by: V. F. Achikyan, et al.
Published: (2024-04-01)

Drug-induced second tumors: a disproportionality analysis of the FAERS database
by: Shupeng Chen, et al.
Published: (2025-05-01)

Prognostic value of baseline and absolute change of inflammatory markers in patients with thymic epithelial tumors
by: Huiting Li, et al.
Published: (2025-12-01)

Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real‐World Study
by: Patrick Foy, et al.
Published: (2025-04-01)

Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real‐World Setting
by: Levon Demirdjian, et al.
Published: (2025-02-01)

Research on Application of Medical Device Real-World Evidence in Regulatory Decisions of the United States
by: Xiaofang GU, et al.
Published: (2025-07-01)

Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
by: T. Macarulla, et al.
Published: (2025-03-01)

Use of transportability methods for real-world evidence generation: a review of current applications
by: Natalie S Levy, et al.
Published: (2024-10-01)

Real‐world assessment of comprehensive genome profiling impact on clinical outcomes: A single‐institution study in Japan
by: Kei Kunimasa, et al.
Published: (2024-09-01)

The role of circulating tumor DNA (ctDNA) in urothelial cancers
by: Jeanny B. Aragon-Ching
Published: (2025-05-01)

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Zhe Wang, et al.
Published: (2025-05-01)

Educational pharmacoepidemiology and "Real-World Knowledge"
by: R. A. Bontsevich
Published: (2025-01-01)

Real‐world genomic landscape of colon and rectal cancer
by: Markus Schulze, et al.
Published: (2025-04-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
by: Hang Yuan, et al.
Published: (2025-07-01)

DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union
by: K. S. Radaeva, et al.
Published: (2023-01-01)

Core variables for real-world clinicogenomic data collection in precision oncology
by: R. Dienstmann, et al.
Published: (2025-03-01)

Safety and efficacy of generic nab-paclitaxel-based therapy in Chinese patients with malignant tumors in a real-world setting: a multicenter prospective observational study
by: Fei He, et al.
Published: (2024-11-01)

Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine products
by: Chieko Ishiguro, et al.
Published: (2025-12-01)

Resolution based on the results of the III annual scientific and practical conference «Real clinical practice in a changing world. Challenges and Solutions»
by: A. S. Kolbin
Published: (2022-11-01)

An overview of real-world study in clinical transfusion
by: GONG Jiashun, et al.
Published: (2025-07-01)

Resolution based on the results of the IV annual scientific-practical conference "Real clinical practice. Modernity and the future"
by: A. S. Kolbin
Published: (2023-12-01)

ICH Reflection paper on proposed international harmonization of real-world evidence terminology and convergence of general principles regarding planning and reporting of studies using real-world data, with a focus on effectiveness of drugs
by: K. S. Radaeva, et al.
Published: (2023-10-01)

ESMO Guidance for Reporting Oncology real-World evidence (GROW)
by: L. Castelo-Branco, et al.
Published: (2023-11-01)

Development and validation of a prognostic model for post-surgical overall survival in Asian colon cancer patients: a real-world population-based study
by: Cheng Liu, et al.
Published: (2025-04-01)

EBANO study: real-world data from patients with locally advanced/metastatic urothelial carcinoma (la/mUC) in Northern Spain
by: R. Fernández Rodríguez, et al.
Published: (2024-12-01)

Review of data sources used in real-world traumatology and orthopedic
by: I. U. Zolotukhina, et al.
Published: (2023-12-01)

Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review
by: Patricia A. Meza-Meneses, et al.
Published: (2025-04-01)

Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
by: Giampiero Girolomoni, et al.
Published: (2024-12-01)

Use of real-world data as pivotal evidence in veterinary regulatory applications
by: Raffaele Bruno
Published: (2025-06-01)

Requirements and Technical Aspects of Real world Data Governance in China's Medical Standards and Specifications
by: GUAN Xinmiao, et al.
Published: (2024-09-01)

Real-World Evidence and Managed Entry Agreements
by: Silvia Adami, et al.
Published: (2025-07-01)

Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases
by: Ye-Seul Lee, et al.
Published: (2023-12-01)

Tumor-colonizing Lachnoclostridium-mediated chemokine expression enhances the immune infiltration of bladder urothelial carcinoma
by: Liang Chen, et al.
Published: (2025-01-01)